Multicenter Study on Adult Growth Hormone Level in Postoperative Pituitary Tumor Patients

被引:2
|
作者
Cheng, Jing-Min [1 ,2 ]
Gu, Jian-Wen [1 ,3 ]
Kuang, Yong-Qin [1 ]
Ma, Yuan [1 ,2 ]
Xia, Xun [1 ,2 ]
Yang, Tao [1 ,2 ]
Lu, Min [1 ,2 ]
He, Wei-Qi [1 ]
Sun, Zhi-Yong [1 ,2 ]
Zhang, Yan-Chao [1 ,2 ]
机构
[1] Chengdu Mil Gen Hosp, Dept Neurosurg, Chengdu 610083, Sichuan Provinc, Peoples R China
[2] Third Mil Med Univ, Grad Management Team, Chongqing 400038, Peoples R China
[3] Air Force Gen Hosp PLA, Beijing, Peoples R China
关键词
Pituitary tumor; Post-operation; Adult growth hormone; IGF-1; LEVELS; DEFICIENCY; ADENOMAS; SURGERY; CLASSIFICATION; MANAGEMENT; RESECTION; APOPLEXY; DENSITY;
D O I
10.1007/s12013-014-0334-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study is to observe the adult growth hormone level in postoperative pituitary tumor patients of multi-centers, and explore the change of hypophyseal hormones in postoperative pituitary tumor patients. Sixty patients with pituitary tumor admitted during March, 2011-March, 2012 were selected. Postoperative hypophyseal hormone deficiency and the change of preoperative, intraoperative, and postoperative growth hormone levels were recorded. Growth hormone hypofunction was the most common hormonal hypofunction, which took up to 85.0 %. Adrenocortical hormone hypofunction was next to it and accounted for 58.33 %. GH + ACTH + TSH + Gn deficiency was the most common in postoperative hormone deficiency, which took up to 40.00 %, and GH + ACTH + TSH + Gn + AVP and GH deficiencies were next to it and accounted for 23.33 and 16.67 %, respectively. The hormone levels in patients after total pituitary tumor resection were significantly lower than those after partial pituitary tumor resection, and the difference was statistically significant; growth hormone and serum prolactin levels after surgery in two groups were decreased, and the difference was statistically significant. The incidence rate of growth hormone deficiency in postoperative pituitary tumor patients is high, which is usually complicated with deficiency of various hypophyseal hormones. In clinical, we should pay attention to the levels of the hypopnyseal hormones, and take timely measures to avoid postoperative complications.
引用
收藏
页码:1239 / 1242
页数:4
相关论文
共 50 条
  • [1] Multicenter Study on Adult Growth Hormone Level in Postoperative Pituitary Tumor Patients
    Jing-min Cheng
    Jian-wen Gu
    Yong-qin Kuang
    Yuan Ma
    Xun Xia
    Tao Yang
    Min Lu
    Wei-qi He
    Zhi-yong Sun
    Yan-chao Zhang
    Cell Biochemistry and Biophysics, 2015, 71 : 1239 - 1242
  • [2] Stereotactic radiosurgery for nonfunctioning pituitary tumor: A multicenter study of new pituitary hormone deficiency
    Dumot, Chloe
    Mantziaris, Georgios
    Dayawansa, Sam
    Peker, Selcuk
    Samanci, Yavuz
    Nabeel, Ahmed M.
    Reda, Wael A.
    Tawadros, Sameh R.
    Abdelkarim, Khaled
    El-Shehaby, Amr M. N.
    Emad, Reem M.
    Abdelsalam, Ahmed Ragab
    Liscak, Roman
    May, Jaromir
    Mashiach, Elad
    Vasconcellos, Fernando De Nigris
    Bernstein, Kenneth
    Kondziolka, Douglas
    Speckter, Herwin
    Mota, Ruben
    Brito, Anderson
    Bindal, Shray Kumar
    Niranjan, Ajay
    Lunsford, Dade L.
    Benjamin, Carolina Gesteira
    Almeida, Timoteo Abrantes de Lacerda
    Mao, Jennifer
    Mathieu, David
    Tourigny, Jean-Nicolas
    Tripathi, Manjul
    Palmer, Joshua David
    Matsui, Jennifer
    Crooks, Joe
    Wegner, Rodney E.
    Shepard, Matthew J.
    Vance, Mary Lee
    Sheehan, Jason P.
    NEURO-ONCOLOGY, 2024, 26 (04) : 715 - 723
  • [3] Growth Hormone Is Beneficial for Induction of Spermatogenesis in Adult Patients With Congenital Combined Pituitary Hormone Deficiency
    Zhu, Yiyi
    Nie, Min
    Wang, Xi
    Huang, Qibin
    Yu, Bingqing
    Zhang, Rui
    Zhang, Junyi
    Sun, Bang
    Mao, Jiangfeng
    Wu, Xueyan
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [4] A novel "total pituitary hormone index" as an indicator of postoperative pituitary function in patients undergoing resection of pituitary adenomas
    Wang, Shousen
    Li, Biao
    Ding, Chenyu
    Xiao, Deyong
    Wei, Liangfeng
    ONCOTARGET, 2017, 8 (45) : 79111 - 79125
  • [5] Postoperative growth hormone dynamics in clinically nonfunctioning pituitary adenoma
    Kobayashi, Nobuyuki
    Yamaguchi-Okada, Mitsuo
    Horiguchi, Kentaro
    Fukuhara, Noriaki
    Nishioka, Hiroshi
    Yamada, Shozo
    ENDOCRINE JOURNAL, 2018, 65 (08) : 827 - 832
  • [6] Significance of postoperative fluid diuresis in patients undergoing transsphenoidal surgery for growth hormone-secreting pituitary adenomas Clinical article
    Zada, Gabriel
    Sivakumar, Walavan
    Fishback, Dawn
    Singer, Peter A.
    Weiss, Martin H.
    JOURNAL OF NEUROSURGERY, 2010, 112 (04) : 744 - 749
  • [7] Autophagy inhibition suppresses hormone production and cell growth in pituitary tumor cells: A potential approach to pituitary tumors
    Satou, Motoyasu
    Wang, Jason
    Nakano-Tateno, Tae
    Teramachi, Mariko
    Aoki, Shigeki
    Sugimoto, Hiroyuki
    Chik, Constance
    Tateno, Toru
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2024, 586
  • [8] Clinical Management of Postoperative Growth Hormone Deficiency in Hypothalamic-Pituitary Tumors
    Iglesias, Pedro
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [9] Pituitary adenoma consistency affects postoperative hormone function: a retrospective study
    De Alcubierre, Dario
    Puliani, Giulia
    Cozzolino, Alessia
    Hasenmajer, Valeria
    Minnetti, Marianna
    Sada, Valentina
    Martines, Valentina
    Zaccagnino, Antonella
    Ruggeri, Andrea Gennaro
    Pofi, Riccardo
    Sbardella, Emilia
    Venneri, Mary Anna
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [10] Genome wide analysis of circulating miRNAs in growth hormone secreting pituitary neuroendocrine tumor patients' plasma
    Niedra, Helvijs
    Peculis, Raitis
    Litvina, Helena Daiga
    Megnis, Kaspars
    Madrika, Ilona
    Balcere, Inga
    Romanovs, Mihails
    Steina, Liva
    Stukens, Janis
    Breiksa, Austra
    Nazarovs, Jurijs
    Sokolovska, Jelizaveta
    Liutkeviciene, Rasa
    Vilkevicute, Alvita
    Konrade, Ilze
    Rovite, Vita
    FRONTIERS IN ONCOLOGY, 2022, 12